Inventor
DAVID SAMUEL
DE26 patents
⚠️ This page may combine multiple inventors who share the name “DAVID SAMUEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KALI CHEMIE PHARMA GMBH
12 patentsUS5438068AAug 1, 1995
Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
KALI CHEMIE PHARMA GMBH12 citations73
US4391819AJul 5, 1983
2,9-Dioxa tricyclo [4,3,1,03,7 ] decane compounds and process of making same
KALI CHEMIE PHARMA GMBH9 citations72
US5294638AMar 15, 1994
Phenyalkylaminoalkyl compounds and pharmaceutical compositions containing them
KALI CHEMIE PHARMA GMBH13 citations70
US4182889AJan 8, 1980
Process for preparing 10-methyl-2,9-dioxatricyclo[4,3,1,03,7 ] decanes
KALI CHEMIE PHARMA GMBH4 citations61
US4158061AJun 12, 1979
2,9-Dioxatricyclo[4,3,1,03,7 ] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
KALI CHEMIE PHARMA GMBH3 citations61
US4141988AFeb 27, 1979
2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives, processes for their preparation and pharmaceutical compositions thereof
KALI CHEMIE PHARMA GMBH3 citations61
US4980487ADec 25, 1990
Novel valepotriate hydrin containing medicines
KALI CHEMIE PHARMA GMBH4 citations60
US4117148ASep 26, 1978
2,9-Dioxatricyclo [4,3,1,0,3,7] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
KALI CHEMIE PHARMA GMBH2 citations59
US5212173AMay 18, 1993
Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them
KALI CHEMIE PHARMA GMBH4 citations58
US4207331AJun 10, 1980
2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives and pharmaceutical compositions thereof
KALI CHEMIE PHARMA GMBH1 citations50
US4714709ADec 22, 1987
N-(2,10-dioxa-tricyclo-[5,3,1,03,8 ]-undecane-5-yl)-tryptamine derivatives and medical compositions thereof
KALI CHEMIE PHARMA GMBH0 citations47
US4891384AJan 2, 1990
Valepotriate hydrin containing medicines used to treat uclers and motility disturbances
KALI CHEMIE PHARMA GMBH0 citations46
SOLVAY PHARM GMBH
7 patentsUS7241770B2Jul 10, 2007
Hydronopol derivatives as agonists on human ORL1 receptors
SOLVAY PHARM GMBH23 citations88
US6001833ADec 14, 1999
Urea derivatives
SOLVAY PHARM GMBH10 citations72
US7238470B2Jul 3, 2007
Method of treating or inhibiting obesity
SOLVAY PHARM GMBH9 citations71
US6946243B2Sep 20, 2005
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
SOLVAY PHARM GMBH4 citations71
US6770649B2Aug 3, 2004
1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH2 citations61
US7282325B2Oct 16, 2007
Method of preparing pharmaceutical compositions
SOLVAY PHARM GMBH0 citations50
US6040303AMar 21, 2000
7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
SOLVAY PHARM GMBH0 citations40